Antibody-targeted cell fusion

Nature Biotechnology

Volumn 22, Issue 3, 2004, Pages 331-336

  Nakamura, Takafumi ^a   Peng, Kah Whye ^a   Vongpunsawad, Sompong ^a   Harvey, Mary ^a   Mizuguchi, Hiroyuki ^b   Hayakawa, Takao ^c   Cattaneo, Roberto ^a   Russell, Stephen J ^a  

^a MAYO CLINIC   (United States)

^b Div of Cell and Gene Ther Prod   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOLOGICAL MEMBRANES; CELLS; COMPLEXATION; PROTEINS; VIRUSES;

CELL FUSION; EPIDERMAL GROWTH FACTOR RECEPTORS (EGFR);

BIOTECHNOLOGY;

ADENOVIRUS VECTOR; ANTIBODY; CD150 ANTIGEN; CD38 ANTIGEN; EPIDERMAL GROWTH FACTOR; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANTIBODY TARGETED CELL FUSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUSION; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEASLES VIRUS; MEMBRANE FUSION; NONHUMAN; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; ANTIGENS, CD46; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DRUG DELIVERY SYSTEMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASMS; PROTEIN ENGINEERING; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; TREATMENT OUTCOME; VERO CELLS;

ADENOVIRIDAE; ANIMALIA; MEASLES VIRUS; VECTORS;

EID: 1542306846     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt942     Document Type: Article

References (37)

1. Shemer, G. & Podbilewicz, B. Fusomorphogenesis: cell fusion in organ formation. Dev. Dyn. 218, 30-51 (2000).
2. Holden, C. & Vogel, G. Stem cells. Plasticity: time for a reappraisal. Science 296, 2126-2129 (2002).
3. Griffin, D.E. Measles Virus. in Fields Virology (eds. Knipe, D.M. & Howley, P.M.) 1402-1442 (Lippincott Williams & Wilkins, Philadelphia, 2001).
4. Freed, E.O. & Martin, M.A. HIVs and their replication, in Fields Virology (eds. Knipe, D.M. & Howley, P.M.) 1971-2042 (Lippincott Williams & Wilkins, Philadelphia, 2001).
5. Cohen, J.I. & Straus, S.E. Varicella-Zoster virus and its replication, in Fields Virology (eds. Knipe, D.M. & Howley, P.M.) 2707-2730 (Lippincott Williams & Wilkins, Philadelphia, 2001).
6. Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497 (1975).
7. Dorssers, L.C. & Veldscholte, J. Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells. Int. J. Cancer 72, 700-7005 (1997).
8. Dieken, E.S., Epner, E.M., Fiering, S., Fournier, R.E. & Groudine, M. Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microcell hybrids. Nat. Genet. 12, 174-182, (1996).
9. Galanis, E. et al. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum. Gene Ther. 12, 811-821 (2001).
10. Peng, K.W. et al. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 62, 4656-4662 (2002).
11. Guo, Y. et al. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263, 518-520 (1994).
12. Bateman, A. et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 60, 1492-1497 (2000).
13. Dorig, R.E., Marcil, A., Chopra, A. & Richardson, C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305 (1993).
14. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897 (2000).
15. von Messling, V., Zimmer, G., Herrler, G., Haas, L. & Cattaneo, R. The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J. Virol. 75, 6418-6427 (2001).
16. Hammond, A.L. et al. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J. Virol. 75, 2087-2097 (2001).
17. Peng, K.W. et al. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 101, 2557-2562 (2003).
18. Lecouturier, V. et al. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70, 4200-4204 (1996).
19. Vongpunsawad, S., Oezgum, N., Braun, W. & Cattaneo, R. Selectively receptor-bind measles viruses: Identification of the SLAM-and CD46-interacting residues and their localization on a new hemagglutinin structural model. J. Virol. 78, 302-313 (2004).
20. Xie, M., Tanaka, K., Ono, N., Minagawa, H. & Yanagi, Y. Amino acid substitutions at position 481 differently affect the ability of the measles virus hemagglutinin to induce cell fusion in monkey and marmoset cells co-expressing the fusion protein. Arch. Virol. 144, 1689-1699 (1999).
21. Cattaneo, R. & Rose, J.K. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 67, 1493-1502 (1993).
22. Chester K.A. et al. Phage libraries for generation of clinically useful antibodies. Lancet 343, 455-456 (1994).
23. Kettleborough, C.A., Saldanha, J., Heath, V.J., Morrison, C.J. & Bendig, M.M. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. Protein Eng. 4, 773-783 (1991).
24. Wang, G. et al. A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen. Nat. Med. 4, 168-172 (1998).
25. Wang, X. et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422, 897-901 (2003).
26. Mehta, K., Shahid, U. & Malavasi, F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 10, 1408-1417 (1996).
27. Obrink, B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr. Opin. Cell Biol. 9, 616-626 (1997).
28. Carpenter, G. Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB J. 6, 3283-3289 (1992).
29. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392 (2003).
30. Schneider, U., Bullough, F., Vongpunsawad, S., Russell, S.J. & Cattaneo, R. Recombinant measles viruses efficiently entering cells through targeted receptors. J. Virol. 74, 9928-9936 (2000).
31. Robbins, P.F. et al. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res. 51, 3657-3662 (1991).
32. Cathomen, T., Buchholz, C.J., Spielhofer, P. & Cattaneo, R. Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology 214, 628-632 (1995).
33. Mizuguchi, H., Xu, Z.L., Sakurai, F., Mayumi, T. & Hayakawa, T. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum. Gene Ther. 14, 1265-1277 (2003).
34. Firsching, R. et al. Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol. 73, 5265-5273 (1999).
35. Kanegae, Y. et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl. Acids Res. 23, 3816-3821 (1995).
36. Mittereder, N., March, K.L. & Trapnell, B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509 (1996).
37. Langedijk, J.P., Daus, F.J., & van Oirschot, J.T. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin, J. Virol. 71, 6155-6167 (1997).